Article Text

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil
  1. J B Jonas
  1. Department of Ophthalmology, Faculty for Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Germany
  1. Correspondence to: Universitäts-Augenklinik, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim, Germany; Jost.Jonas{at}augen.ma.uni-heidelberg.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

For decades, corticosteroids have been known to reduce inflammation and, depending on their concentration, to suppress proliferation of cells. Applied either locally or systemically, steroids have consequently been used for treatment of various ocular diseases. Often, however, the intraocular concentrations of cortisone were not sufficiently high, or the systemic side effects were too pronounced, to effectively treat the ocular disorder. Taking into account that the eye comprises only 0.01% of the whole body volume, and considering that for achieving high concentrations of a drug at its site of action it is best to apply it directly into the region of …

View Full Text

Footnotes

  • Proprietary interest: none.